About Hepatitis A virus cellular receptor 1
Hepatitis A virus cellular receptor 1 (HAVCR1) is a protein
from Homo sapiens identified by UniProt accession
Q96D42, 364 residues long.
MolForge cross-references it against 0 known binders and
445 disease associations.
Target properties
| Protein name | Hepatitis A virus cellular receptor 1 |
| UniProt accession | Q96D42 |
| Gene | HAVCR1 |
| Organism | Homo sapiens |
| Length | 364 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (445)
Diseases linked to this target (Open Targets).
- COVID-19 · score 0.48
- blood protein measurement · score 0.47
- kidney injury molecule 1 measurement · score 0.46
- low density lipoprotein cholesterol measurement · score 0.44
- neutrophil count · score 0.44
- leukocyte count · score 0.40
- myeloid white cell count · score 0.37
- alcohol consumption measurement · score 0.36
- alcohol drinking · score 0.32
- T-cell immunoglobulin and mucin domain 1 measurement · score 0.32
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96D42-F1 | alphafold | PREDICTED | 65.79 | — |
Amino-acid sequence (364 residues)
MHPQVVILSL ILHLADSVAG SVKVGGEAGP SVTLPCHYSG AVTSMCWNRG SCSLFTCQNG IVWTNGTHVT YRKDTRYKLL GDLSRRDVSL TIENTAVSDS GVYCCRVEHR GWFNDMKITV SLEIVPPKVT TTPIVTTVPT VTTVRTSTTV PTTTTVPMTT VPTTTVPTTM SIPTTTTVLT TMTVSTTTSV PTTTSIPTTT SVPVTTTVST FVPPMPLPRQ NHEPVATSPS SPQPAETHPT TLQGAIRREP TSSPLYSYTT DGNDTVTESS DGLWNNNQTQ LFLEHSLLTA NTTKGIYAGV CISVLVLLAL LGVIIAKKYF FKKEVQQLSV SFSSLQIKAL QNAVEKEVQA EDNIYIENSL YATD
Explore Hepatitis A virus cellular receptor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets